DE3786256D1 - Antifolat-mittel. - Google Patents
Antifolat-mittel.Info
- Publication number
- DE3786256D1 DE3786256D1 DE8787907792T DE3786256T DE3786256D1 DE 3786256 D1 DE3786256 D1 DE 3786256D1 DE 8787907792 T DE8787907792 T DE 8787907792T DE 3786256 T DE3786256 T DE 3786256T DE 3786256 D1 DE3786256 D1 DE 3786256D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- agents
- group
- formula
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868628731A GB8628731D0 (en) | 1986-12-02 | 1986-12-02 | Antifolate agents |
GB878721283A GB8721283D0 (en) | 1987-09-10 | 1987-09-10 | Antifolate agents |
GB878721284A GB8721284D0 (en) | 1987-09-10 | 1987-09-10 | Antifolate agents |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3786256D1 true DE3786256D1 (de) | 1993-07-22 |
DE3786256T2 DE3786256T2 (de) | 1993-10-07 |
Family
ID=27263226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE87907792T Expired - Fee Related DE3786256T2 (de) | 1986-12-02 | 1987-11-30 | Antifolat-mittel. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4992444A (de) |
EP (1) | EP0290558B1 (de) |
JP (1) | JP2704747B2 (de) |
AT (1) | ATE90673T1 (de) |
DE (1) | DE3786256T2 (de) |
GB (1) | GB2204867B (de) |
WO (1) | WO1988004293A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5704594A (en) * | 1992-12-18 | 1994-07-19 | Wellcome Foundation Limited, The | Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors |
GB9226377D0 (en) * | 1992-12-18 | 1993-02-10 | Babbedge Rachel C | Pharmaceutical compositions |
US5747476A (en) * | 1996-07-17 | 1998-05-05 | Mortar & Pestle Veterinary Pharmacy, Inc. | Treatment of equine protozoal myeloencephalitis |
GB9700664D0 (en) * | 1997-01-14 | 1997-03-05 | British Tech Group | Anti-cancer agents |
US7371758B2 (en) * | 2003-03-13 | 2008-05-13 | National Science & Technology Development Agency | Antimalarial pyrimidine derivatives and methods of making and using them |
US20050171131A1 (en) * | 2003-09-26 | 2005-08-04 | Christi Kosogof | Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists |
WO2014145386A2 (en) * | 2013-03-15 | 2014-09-18 | University Of Florida Research Foundation Incorporated | Novel allosteric inhibitors of thymidylate synthase |
WO2016209688A1 (en) | 2015-06-24 | 2016-12-29 | University Of Florida Research Foundation, Incorporated | Compositions for the treatment of cancer and uses thereof |
WO2023081141A1 (en) * | 2021-11-02 | 2023-05-11 | University Of Florida Research Foundation, Incorporated | Thymidylate synthase inhibitors and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2903850A1 (de) * | 1979-02-01 | 1980-08-07 | Bayer Ag | 2-amino-8-cyclopropyl-5-oxo-5,8- dihydro-pyrido eckige klammer auf 2,3-d eckige klammer zu -pyrimidin-6-carnonsaeuren, verfahren zu ihrer herstellung sowie ihrer verwendung als antibakterielle mittel |
GB8314643D0 (en) * | 1983-05-26 | 1983-06-29 | Wellcome Found | Pyrimidine derivatives |
GB8410636D0 (en) * | 1984-04-26 | 1984-05-31 | Stevens M F G | Pharmaceutical substances/compositions |
-
1987
- 1987-11-30 DE DE87907792T patent/DE3786256T2/de not_active Expired - Fee Related
- 1987-11-30 AT AT87907792T patent/ATE90673T1/de active
- 1987-11-30 JP JP63500078A patent/JP2704747B2/ja not_active Expired - Lifetime
- 1987-11-30 EP EP87907792A patent/EP0290558B1/de not_active Expired - Lifetime
- 1987-11-30 WO PCT/GB1987/000859 patent/WO1988004293A1/en active IP Right Grant
- 1987-11-30 GB GB8728018A patent/GB2204867B/en not_active Expired - Lifetime
- 1987-12-02 US US07/127,452 patent/US4992444A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1988004293A1 (en) | 1988-06-16 |
JPH01501477A (ja) | 1989-05-25 |
GB2204867A (en) | 1988-11-23 |
EP0290558B1 (de) | 1993-06-16 |
DE3786256T2 (de) | 1993-10-07 |
GB8728018D0 (en) | 1988-01-06 |
US4992444A (en) | 1991-02-12 |
EP0290558A1 (de) | 1988-11-17 |
GB2204867B (en) | 1991-05-29 |
ATE90673T1 (de) | 1993-07-15 |
JP2704747B2 (ja) | 1998-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
MX173630B (es) | Derivados de aminoacido, procedimiento para su preparacion y su preparacion y medicamento que los contiene | |
FI802404A (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva heterocykliska foereningar | |
ATE161836T1 (de) | 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate | |
FI900085A (fi) | Menetelmä terapeuttisesti käyttökelpoisten N-(pyrimidin- ja kondensoitu pyrimidin-4-oni)etyyli-piperidiini- ja piperatsiinijohdannaisten valmistamiseksi | |
FI884375A (fi) | Menetelmä terapeuttisesti käyttökelpoisten N-(1-alkyyli-3-hydroksi-4-piperidinyyli)bentsamidien valmistamiseksi | |
NO921413D0 (no) | Pyrazolopyridin-forbindelser og fremgangsmaate for fremstilling derav | |
DE3786256D1 (de) | Antifolat-mittel. | |
ES2051834T3 (es) | El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad. | |
ES547620A0 (es) | Procedimiento para preparar pirazol (3,4-b) piridinamidas. | |
ES2028838T3 (es) | Procedimiento para la obtencion de nuevos derivados de 4,5-hidro-oxazoles. | |
DE3063525D1 (en) | Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them | |
PT77666A (fr) | Procede de preparation de nouveaux derives de la nitrosouree | |
ES2016305B3 (es) | Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso. | |
GB2152508A (en) | Pyrimidine derivatives | |
KR880004810A (ko) | 소화성 궤양 치료제 | |
ATE44875T1 (de) | 4-amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5carbons|ure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln. | |
DK364386A (da) | 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse | |
TH893EX (th) | การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้ | |
NO823682L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridazinonimin-derivater. | |
TH5602A (th) | สารประกอบทางเภสัชวิทยาชนิดใหม่ | |
TH2131B (th) | การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้ | |
PT89483A (pt) | Processo para a preparacao de derivados da 2-amino acetamida | |
TH5602EX (th) | สารประกอบทางเภสัชวิทยาชนิดใหม่ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |